These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8796866)
1. New methodology for the evaluation of novel therapies in cancer. Gore M Mol Med Today; 1996 Mar; 2(3):103-5. PubMed ID: 8796866 [No Abstract] [Full Text] [Related]
2. Gene-modified cells for the treatment of cancer. Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929 [TBL] [Abstract][Full Text] [Related]
3. Growing number of biological therapies head toward clinical trials. Waalen J J Natl Cancer Inst; 1992 Dec; 84(23):1772-4. PubMed ID: 1433364 [No Abstract] [Full Text] [Related]
4. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245 [TBL] [Abstract][Full Text] [Related]
5. Clinical development of antisense oligonucleotides as anti-cancer therapeutics. Chen HX Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768 [No Abstract] [Full Text] [Related]
7. [Current status and future perspective of cancer immunotherapy--clinical application and development]. Aruga A Nihon Geka Gakkai Zasshi; 2013 Nov; 114(6):327-31. PubMed ID: 24358730 [No Abstract] [Full Text] [Related]
10. New agents in the treatment of CLL. O'Brien S Hematology Am Soc Hematol Educ Program; 2008; ():457-64. PubMed ID: 19074126 [TBL] [Abstract][Full Text] [Related]
11. Biomodulators in cancer treatment. Mitchell MS J Clin Pharmacol; 1992 Jan; 32(1):2-9. PubMed ID: 1371295 [No Abstract] [Full Text] [Related]
12. Molecular approaches to cancer therapy. Israel MA Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720 [No Abstract] [Full Text] [Related]
13. New approaches in brain tumor therapy using gene transfer and antisense oligonucleotides. Yung WK Curr Opin Oncol; 1994 May; 6(3):235-9. PubMed ID: 8080851 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in cancer immunotherapy. Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types. Ascierto PA; Kalos M; Schaer DA; Callahan MK; Wolchok JD Clin Cancer Res; 2013 Mar; 19(5):1009-20. PubMed ID: 23460532 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for pancreatic cancer: A long and hopeful journey. Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510 [TBL] [Abstract][Full Text] [Related]
17. Antisense anticancer oligonucleotide therapeutics. Wang H; Prasad G; Buolamwini JK; Zhang R Curr Cancer Drug Targets; 2001 Nov; 1(3):177-96. PubMed ID: 12188878 [TBL] [Abstract][Full Text] [Related]